ArticleBJUI compass2024
New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinoma.
Takafumi Saito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it